Vitamin D2 and D3 Study Retrospective Study
220,000 veterans given D3... Large retrospective study... 33% reduction in mortality rate... Should IPAK do a prospective RCT on Vitamin D3 supplementation?
John Campbell reviews a study published November 2022.
Gibbons JB, Norton EC, McCullough JS, Meltzer DO, Lavigne J, Fiedler VC, Gibbons RD. Association between vitamin D supplementation and COVID-19 infection and mortality. Sci Rep. 2022 Nov 12;12(1):19397. doi: 10.1038/s41598-022-24053-4. PMID: 36371591; PMCID: PMC9653496.
The study found (among other very promising results):
20% reduction in COVID-19 cases in people receiving D3.
0.23% mortality rate, 33% mortality rate reduction in people receiving D3.
While it’s not a RCT, John emphasizes that no one will do an RCT on D3 because there is no money in it, so no one will fund it.
Should IPAK do an Randomized Prospective Clinical Trial on Vitamin D3 and respiratory illnesses - not on critically ill or hospitalized patients, instead, given the lag between VitD levels and ingestion, on health patients across the US.
Let me know in your comments.
"RCT" is a euphemism for blind or double blind study. Those are unethical since they deny consent. Don't give them credence. The placebo effect is overrated.
Yes, please! I believe in D3 with K2 and agree their value is being withheld from the public!